Dr Byron D Mcclure Ii, DO | |
2401 Se Hwy 36, Cameron, MO 64429 | |
(816) 632-2415 | |
Not Available |
Full Name | Dr Byron D Mcclure Ii |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 2401 Se Hwy 36, Cameron, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003133398 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 31631 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Byron D Mcclure Ii, DO Po Box 151, Cameron, MO 64429-0151 Ph: (816) 632-2415 | Dr Byron D Mcclure Ii, DO 2401 Se Hwy 36, Cameron, MO 64429 Ph: (816) 632-2415 |
News Archive
Research released today reveals a new model for a genetic eye disease, and shows how animal models - from fruit flies to armadillos and monkeys - can yield valuable information about the human brain. The findings were presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
The initial results of the CombivacS trial found that the antibody levels in individuals increased by 150 times when the Pfizer messenger ribonucleic acid (mRNA) vaccine was given after a first dose of the AstraZeneca severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, with only mild common side effects.
For people suffering from rheumatoid arthritis, pain is the crucial factor in their personal perception of the condition. The doctors treating them, however, assess the severity of the disease based on the swelling of the joints. This discrepancy often leads to conflict between patients and their physicians, as a study by Daniel Aletaha and Paul Studenic from the University Department of Internal Medicine III at the MedUni Vienna has now revealed in more detail for the first time.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
Specialized brain proteins that are involved in the removal of damaged nerve cell materials may be detected in the blood of people who were diagnosed with mild cognitive impairment or dementia due to Alzheimer's disease.
› Verified 8 days ago